Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis

Background: Aberrant hypermethylation of the Septin 9 (SEPT9) is an early event in several human cancers, and increasing studies have reported good performance of methylated SEPT9 (mSEPT9) in cancer diagnosis. Recent studies further focused on its value in cancer prognosis, but results are not clear...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Na, Wang, Ting, Li, Delei, Zhu, Yaowu, Xie, Huaping, Lu, Yanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761278/
https://www.ncbi.nlm.nih.gov/pubmed/31608117
http://dx.doi.org/10.3389/fgene.2019.00887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761278/
https://www.ncbi.nlm.nih.gov/pubmed/31608117
http://dx.doi.org/10.3389/fgene.2019.00887

Ejemplares similares